ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Is this ASX healthcare stock ready to rocket post-merger?"
Episode Synopsis
Integral Diagnostics (ASX:IDX) had a great year in 2024; its share price was up around 50% as its business recovered from the post-Covid doldrums. It has just completed a merger with Capitol Health to make it Australia’s second largest radiology provider and IML portfolio manager Marc Whittaker believes this has it well set up for its next phase of growth.
In this podcast Marc discusses why Integral Diagnostics is one of his highest conviction holdings in IML’s small and mid cap funds.
In this podcast Marc discusses why Integral Diagnostics is one of his highest conviction holdings in IML’s small and mid cap funds.
More episodes of the podcast Navigating the noise – conversations with the Natixis Investment Managers Expert Collective.
IML's top small cap for 2025
10/12/2025
IML large caps – Sept 2025 quarterly update
10/10/2025
Reporting season: extreme reactions abound
25/08/2025
In God we trust